1-13 of 13
Rajmonda Fjerza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IWG-MRT 2013 Criteria-Based Assessment of Response Among 83 Patients with Myelofibrosis Treated with JAK Inhibitors: Experience of Two Centers

Lisa Pieri, MD PhD, Emanuela Sant'Antonio, MD, Elisa Rumi, MD, Paola Guglielmelli, MD PhD, Rajmonda Fjerza, MD, Chiara Paoli, BS, Lucia Merli, BSN, Mario Cazzola, MD, Alessandro M. Vannucchi
Journal: Blood
Blood (2015) 126 (23): 1615.
https://doi.org/10.1182/blood.V126.23.1615.1615
Published: 2015
Journal Articles

JAK2V617F Clonal Architecture in MPNs during JAK2 Inhibitor Treatment

Annalisa Pacilli, PhD, Paola Guglielmelli, MD PhD, Tiziana Fanelli, MSc, Alessandro Pancrazzi, BS, Lisa Pieri, MD PhD, Rajmonda Fjerza, MD, Alessandro M. Vannucchi
Journal: Blood
Blood (2015) 126 (23): 1630.
https://doi.org/10.1182/blood.V126.23.1630.1630
Published: 2015
Journal Articles

Long Term Follow up of a Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm

Lisa Pieri, MD PhD, Chiara Paoli, BS, Umberto Arena, MD, Fabio Marra, MD, Fabio Mori, MD, Mery Zucchini, MD, Stefano Colagrande, MD, Alessandro Castellani, MD, Arianna Masciulli, PhD MSc, Vittorio Rosti, MD, Valerio De Stefano, MD, Silvia Betti, MD, Guido Finazzi, MD, Maria Luisa Ferrari, BSc, Elisa Rumi, MD, Marco Ruggeri, MD, Ilaria Nichele, MD, Paola Guglielmelli, MD PhD, Rajmonda Fjerza, MD, Carmela Mannarelli, MSc, Tiziana Fanelli, MSc, Lucia Merli, BSN, Margherita Massa, PhD, Giuseppe Cimino, MD, Alessandro Rambaldi, MD, Giovanni Barosi, MD, Mario Cazzola, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2015) 126 (23): 2803.
https://doi.org/10.1182/blood.V126.23.2803.2803
Published: 2015
Journal Articles

JAK2 V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib

Clinical Trials & Observations
Lisa Pieri, Alessandro Pancrazzi, Annalisa Pacilli, Claudia Rabuzzi, Giada Rotunno, Tiziana Fanelli, Paola Guglielmelli, Rajmonda Fjerza, Chiara Paoli, Srdan Verstovsek, Alessandro M. Vannucchi
Journal: Blood
Blood (2015) 125 (21): 3352–3353.
https://doi.org/10.1182/blood-2015-01-624536
Published: 2015
Journal Articles

JAK2 V617F Complete Molecular Remission in Long-Term Follow-up of Patients with Polycythemia Vera and Essential Thrombocythemia Treated with Ruxolitinib

Lisa Pieri, MDPhD, Alessandro Pancrazzi, MSc, Annalisa Pacilli, PhD, Claudia Rabuzzi, BSci, Giada Rotunno, MSc, Paola Guglielmelli, MD PhD, Rajmonda Fjerza, MD, Chiara Paoli, MSc, Tiziana Fanelli, MSc, Alberto Bosi, MD, Srdan Verstovsek, MD PhD, Alessandro Maria Vannucchi, MD
Journal: Blood
Blood (2014) 124 (21): 3185.
https://doi.org/10.1182/blood.V124.21.3185.3185
Published: 2014
Journal Articles

A Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm: A Study from the AGIMM Group

Lisa Pieri, MDPhD, Chiara Paoli, MSc, Umberto Arena, MD, Fabio Marra, MD, Alessandro Castellani, MD, Stefano Colagrande, MD, Fabio Mori, MD, Arianna Masciulli, MSc, PhD, Silvia Betti, MD, Vittorio Rosti, MD, Ilaria Nichele, MD, Guido Finazzi, MD, Maria Luisa Ferrari, MD, Elisa Rumi, MD, Paola Guglielmelli, MD PhD, Rajmonda Fjerza, MD, Carmela Mannarelli, MSc, Tiziana Fanelli, MSc, Alberto Bosi, MD, Giuseppe Cimino, MD, Francesco Passamonti, MD, Valerio De Stefano, MD, Marco Ruggeri, MD, Mario Cazzola, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro Maria Vannucchi, MD
Journal: Blood
Blood (2014) 124 (21): 3192.
https://doi.org/10.1182/blood.V124.21.3192.3192
Published: 2014
Journal Articles

Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2 V617F Mutation: A Study from the AGIMM Group

Paola Guglielmelli, MD PhD, Giada Rotunno, MSc, Giada Brogi, BSci, Annalisa Pacilli, PhD, Costanza Bogani, PhD, Carmela Mannarelli, MSc, Alessandro Pancrazzi, MSc, Rajmonda Fjerza, MD, Lisa Pieri, MDPhD, Elisa Rumi, MD, Daniela Pietra, PhD, Federica Delaini, BiolSC, Silvia Salmoiraghi, BiolSc, Aldesia Provenzano, BSci, Laura Giunti, BSci, Sabrina Giglio, MD, Margherita Maffioli, MD, Alberto Bosi, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Francesco Passamonti, MD, Mario Cazzola, MD, Alessandro Maria Vannucchi, MD
Journal: Blood
Blood (2014) 124 (21): 3179.
https://doi.org/10.1182/blood.V124.21.3179.3179
Published: 2014
Journal Articles

Impact of Mutation Status of ASXL1, EZH2, SRSF2, IDH1/2 on Clinical Phenotype and Prognosis in Patients with Post-Polycythemia and Post-Essential Thrombocythemia Myelofibrosis: An AGIMM Study

Giada Rotunno, MSc, Annalisa Pacilli, PhD, Giada Brogi, BSci, Valentina Artusi, MSc, Elisa Rumi, MD, Federica Delaini, BiolSC, Carmela Mannarelli, MSc, Flavia Biamonte, MSc, PhD, Rajmonda Fjerza, MD, Lisa Pieri, MDPhD, Daniela Pietra, PhD, Clara Belotti, BSci, Enrico Tagliafico, MD PhD, Rossella Manfredini, PhD, Isabella Bernardis, MSc, Alberto Bosi, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Alessandro Maria Vannucchi, MD, Paola Guglielmelli, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1867.
https://doi.org/10.1182/blood.V124.21.1867.1867
Published: 2014
Journal Articles

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

CME Clinical Trials & Observations
Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Christy Finke, Emnet A. Wassie, Lisa Pieri, Naseema Gangat, Rajmonda Fjerza, Alem A. Belachew, Terra L. Lasho, Rhett P. Ketterling, Curtis A. Hanson, Alessandro Rambaldi, Guido Finazzi, Juergen Thiele, Tiziano Barbui, Animesh Pardanani, Alessandro M. Vannucchi
Journal: Blood
Blood (2014) 124 (16): 2507–2513.
https://doi.org/10.1182/blood-2014-05-579136
Published: 2014
Includes: Supplemental data
Journal Articles

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study

Clinical Trials & Observations Brief Report
Paola Guglielmelli, Flavia Biamonte, Giada Rotunno, Valentina Artusi, Lucia Artuso, Isabella Bernardis, Elena Tenedini, Lisa Pieri, Chiara Paoli, Carmela Mannarelli, Rajmonda Fjerza, Elisa Rumi, Viktoriya Stalbovskaya, Matthew Squires, Mario Cazzola, Rossella Manfredini, Claire Harrison, Enrico Tagliafico, Alessandro M. Vannucchi
Journal: Blood
Blood (2014) 123 (14): 2157–2160.
https://doi.org/10.1182/blood-2013-11-536557
Published: 2014
Includes: Supplemental data
Journal Articles

Impact Of Prognostically Detrimental Mutations ( ASXL1, EZH2, SRSF2, IDH1/2 ) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II

Paola Guglielmelli, PhD MD, Flavia Biamonte, BiSci, PhD, Lisa Pieri, MD PhD, Giada Rotunno, BiSci, Chiara Paoli, BiSci, Rajmonda Fjerza, MD, Enrico Tagliafico, MD PhD, Rossella Manfredini, PhD, Valentina Artusi, MSc, Elena Tenedini, PhD, Lucia Artuso, PhD, Isabella Bernardis, Viktoriya Stalbovskaya, PhD, Matthew Squires, PhD, Claire N Harrison, DM, FRCP, FRCPath, Alessandro M Vannucchi, MD
Journal: Blood
Blood (2013) 122 (21): 107.
https://doi.org/10.1182/blood.V122.21.107.107
Published: 2013
Journal Articles

A Phase 2 Study Of Ruxolitinib In Patients With Splanchnic Vein Thrombosis Associated With Myeloproliferative Neoplasm. Preliminary Results

Lisa Pieri, MD, PhD, Chiara Paoli, BiSci, Paola Guglielmelli, PhD MD, Rajmonda Fjerza, MD, Umberto Arena, MD, Fabio Marra, MD, Stefano Colagrande, MD, Fabio Mori, MD, Roberto Marchioli, MD, Raffaella Pioggiarella, PharmD, Marco Ruggeri, MD, Ilaria Nichele, MD, Guido Finazzi, MD, Maria Luisa Ferrari, MD, Vittorio Rosti, MD, Valerio De Stefano, MD, Elisa Rumi, MD, Carmela Mannarelli, BiSci, Tiziana Fanelli, BiSci, Alberto Bosi, Alessandro Rambaldi, MD, Giovanni Barosi, MD, Mario Cazzola, MD, Tiziano Barbui, MD, Alessandro M Vannucchi, MD
Journal: Blood
Blood (2013) 122 (21): 1583.
https://doi.org/10.1182/blood.V122.21.1583.1583
Published: 2013
Journal Articles

Changes of JAK2 V617F Allele Burden Over Time in Patients with Polycythemia Vera or Essential Thrombocythemia: A Retrospective Study of 172 Patients.

Elisabetta Antonioli, MD, Alessandra Carobbio, BStat, Lisa Pieri, MD, Alessandro Pancrazzi, BSc, Paola Guglielmelli, MD, Federica Delaini, BSc, Vanessa Ponziani, PhD, Maria Chiara Susini, MD, Rajmonda Fjerza, MD, Alberto Bosi, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2009) 114 (22): 1892.
https://doi.org/10.1182/blood.V114.22.1892.1892
Published: 2009